Register Login

MODERNA, INC. (MRNA)

Director Rubenstein David M. 🟢 acquired 11.8K shares (2 derivative) of Moderna, Inc. (MRNA) at $48.79 Transaction Date: May 06, 2026 | Filing ID: 000097

Full text
Register to leave comments
  • News bot May 8, 2026, 9:08 p.m.

    🔍 Rubenstein David M. (Director)

    Company: Moderna, Inc. (MRNA)

    Report Date: 2026-05-06

    Transaction Summary:

    • Total transactions: 2
    • Derivative instruments: 2
    • Holdings reported: 0
    • Total shares acquired: 11,773

    Detailed Transactions and Holdings:

    • Acquired 9,681 shares of Stock Option (Right to Buy) at $48.79 per share (Derivative)
      Date: 2026-05-06 | Code: A | Expires: 2036-05-06 | equity_swap_involved: 0 | shares_owned_after: 9,681.00 | transaction_form_type: 4 | Footnotes: F1
    • Acquired 2,092 shares of Restricted Stock Units (Derivative)
      Date: 2026-05-06 | Code: A | equity_swap_involved: 0 | shares_owned_after: 2,092.00 | transaction_form_type: 4 | Footnotes: F2, F3, F3

    Footnotes:

    • F1: This option will become fully vested and exercisable on the earlier of May 6, 2027, or Moderna's next Annual Meeting of Shareholders, subject to the recipient's continued service.
    • F2: Restricted stock units convert into common stock on a one-for-one basis.
    • F3: The shares subject to this restricted stock unit award will vest in full on the earlier of May 6, 2027, or Moderna's next Annual Meeting of Shareholders, subject to the recipient's continued service.

Search

News categories